Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities.
This report aims to provide a comprehensive presentation of the global market for Autism Spectrum Disorder Diagnosis and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autism Spectrum Disorder Diagnosis and Therapeutics. This report contains market size and forecasts of Autism Spectrum Disorder Diagnosis and Therapeutics in global, including the following market information:
Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Autism Spectrum Disorder Diagnosis and Therapeutics market was valued at US$ 9276 million in 2022 and is projected to reach US$ 12140 million by 2029, at a CAGR of 3.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Autism Spectrum Disorder Diagnosis and Therapeutics key players include Otsuka, AstraZeneca, Pfizer, etc. Global top three manufacturers hold a share about 10%.
Europe is the largest market, with a share about 30%, followed by United States and China, both have a share about 45 percent.
In terms of product, Autistic Disorder is the largest segment, with a share about 35%. And in terms of application, the largest application is Children and Teenagers, followed by Adults.
We surveyed the Autism Spectrum Disorder Diagnosis and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autism Spectrum Disorder Diagnosis and Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Autistic Disorder
- Asperger Syndrome
- Childhood Disintegrative Disorder
- Others
Global Autism Spectrum Disorder Diagnosis and Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Children and Teenagers
- Adults
Global Autism Spectrum Disorder Diagnosis and Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Autism Spectrum Disorder Diagnosis and Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Autism Spectrum Disorder Diagnosis and Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Otsuka
- AstraZeneca
- Pfizer
- Eli Lilly
- Johnson & Johnson
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Autism Spectrum Disorder Diagnosis and Therapeutics, market overview.
- Chapter 2: Global Autism Spectrum Disorder Diagnosis and Therapeutics market size in revenue.
- Chapter 3: Detailed analysis of Autism Spectrum Disorder Diagnosis and Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Autism Spectrum Disorder Diagnosis and Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
